• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Understanding the epidemiology of metabolic dysfunction-associated steatotic liver disease is essential for its management: need for attention to accurate diagnostic coding and classification.了解代谢功能障碍相关脂肪性肝病的流行病学对其管理至关重要：需要关注准确的诊断编码和分类。
Korean J Intern Med. 2024 Nov;39(6):869-871. doi: 10.3904/kjim.2024.351. Epub 2024 Nov 1.
2
Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration.代谢相关脂肪性肝病：术语演变、诊断前沿和治疗视野的探索——述评。
World J Gastroenterol. 2024 May 14;30(18):2387-2390. doi: 10.3748/wjg.v30.i18.2387.
3
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease.脂肪性肝病新命名法的意义及代谢相关脂肪性肝病的定义。
Aliment Pharmacol Ther. 2024 Jan;59(2):150-156. doi: 10.1111/apt.17846.
4
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.用于检测代谢功能障碍相关脂肪性肝病患者显著纤维化的非侵入性检测组合并不优于单独使用磁共振弹性成像。
Eur Radiol. 2024 Jun;34(6):3882-3888. doi: 10.1007/s00330-023-10441-5. Epub 2023 Nov 21.
5
Longitudinal Clinical Outcomes and Mortality from Steatotic Liver Disease: A Meta-Analysis.脂肪性肝病的纵向临床结局与死亡率：一项荟萃分析。
Am J Med. 2025 Apr 30. doi: 10.1016/j.amjmed.2025.04.027.
6
Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) after Liver Transplantation: A Narrative Review of an Emerging Issue.肝移植后代谢功能障碍相关脂肪性肝病（MASLD）：一个新出现问题的叙述性综述
J Clin Med. 2024 Jun 30;13(13):3871. doi: 10.3390/jcm13133871.
7
Menopause and metabolic dysfunction-associated steatotic liver disease.绝经与代谢功能紊乱相关的脂肪性肝病。
Maturitas. 2024 Aug;186:108024. doi: 10.1016/j.maturitas.2024.108024. Epub 2024 May 14.
8
Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center.代谢相关脂肪性肝病在三级中心炎症性肠病中的患病率及相关危险因素。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(6):e20231321. doi: 10.1590/1806-9282.20231321. eCollection 2024.
9
Female reproductive factors and metabolic dysfunction-associated steatotic liver disease: an integrated analysis of population cohort, liver imaging, and genetic data.女性生殖因素与代谢功能障碍相关脂肪性肝病：一项基于人群队列、肝脏影像学和基因数据的综合分析
Am J Obstet Gynecol. 2025 Apr 29. doi: 10.1016/j.ajog.2025.04.007.
10
Practice Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease by the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN).印度儿科学会小儿胃肠病学、肝病学和营养学分会（ISPGHAN）关于代谢功能障碍相关脂肪性肝病的实践建议。
Indian Pediatr. 2024 Oct 15;61(10):919-934. Epub 2024 Sep 13.

本文引用的文献

1
Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022.韩国非酒精性脂肪性肝病的流行趋势演变：2010 年至 2022 年的发病率、患病率、进展及对医疗保健的影响。
Korean J Intern Med. 2024 Nov;39(6):931-944. doi: 10.3904/kjim.2024.164. Epub 2024 Oct 24.
2
Metabolic dysfunction-associated steatotic liver disease and its link to cancer.代谢功能障碍相关脂肪性肝病及其与癌症的联系。
Metabolism. 2024 Nov;160:156004. doi: 10.1016/j.metabol.2024.156004. Epub 2024 Aug 23.
3
Epidemiology of metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的流行病学
Clin Mol Hepatol. 2025 Feb;31(Suppl):S32-S50. doi: 10.3350/cmh.2024.0431. Epub 2024 Aug 19.
4
Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.非酒精性脂肪性肝病各亚型患者的肝硬化和肝细胞癌长期风险
Am J Gastroenterol. 2024 Nov 1;119(11):2241-2250. doi: 10.14309/ajg.0000000000002778. Epub 2024 Mar 7.
5
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications.代谢相关脂肪性肝病：一种伴有心血管和恶性并发症的全身性代谢紊乱疾病。
Gut. 2024 Mar 7;73(4):691-702. doi: 10.1136/gutjnl-2023-330595.
6
Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017-2020.美国脂肪性肝病（MASLD、MetALD 和 ALD）的流行情况：NHANES 2017-2020。
Clin Gastroenterol Hepatol. 2024 Jun;22(6):1330-1332.e4. doi: 10.1016/j.cgh.2023.11.003. Epub 2023 Nov 8.
7
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.代谢相关脂肪性肝病与心血管疾病风险。
Gut. 2024 Feb 23;73(3):533-540. doi: 10.1136/gutjnl-2023-331003.
8
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity.代谢功能障碍相关脂肪性肝病的批判性评价：两面性现代性的启示。
Clin Mol Hepatol. 2023 Oct;29(4):831-843. doi: 10.3350/cmh.2023.0277. Epub 2023 Aug 25.
9
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.超重和肥胖人群中非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球患病率：一项系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Jan;8(1):20-30. doi: 10.1016/S2468-1253(22)00317-X. Epub 2022 Nov 16.

Understanding the epidemiology of metabolic dysfunction-associated steatotic liver disease is essential for its management: need for attention to accurate diagnostic coding and classification.

作者信息

Lee Han Ah

机构信息

Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.

出版信息

Korean J Intern Med. 2024 Nov;39(6):869-871. doi: 10.3904/kjim.2024.351. Epub 2024 Nov 1.

DOI:10.3904/kjim.2024.351
PMID:39551071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11569925/
Abstract
摘要